Bone: from a reservoir of minerals to a regulator of energy metabolism

Slides:



Advertisements
Similar presentations
Bone maintenance, repair, and physiology. A. Bone remodeling
Advertisements

Chronic renal disease: A growing problem
The Ob protein (leptin) and the kidney
THE ENDOCRINE SYSTEM For Wed. Oct. 11 Please print out this powerpoint and fill in the portions with a red * in front of them.
Leptin action in the brain: How (and when) it makes fat burn
Clifford J. Rosen, MD, Anne Klibanski, MD 
Volume 14, Issue 2, Pages (August 2011)
Cellular mechanisms of renal osteodystrophy
Volume 73, Issue 1, Pages 3-5 (January 2008)
FSH versus estrogen: Who's guilty of breaking bones?
The Gutsy Side of Bone Cell Metabolism
Chronic renal disease: A growing problem
Figure 4 Osteocyte regulation of bone formation and resorption
More Than Satiety: Central Serotonin Signaling and Glucose Homeostasis
Hypothalamic leptin and insulin signals regulate several peripheral functions. Hypothalamic leptin and insulin signals regulate several peripheral functions.
Serotonin and the Orchestration of Energy Balance
Looking for food in all the right places?
Michael K. Badman, Jeffrey S. Flier  Gastroenterology 
Felizitas Schmitz, Sara Roscioni, Heiko Lickert  Cell Metabolism 
RIPping off GABA Release in Hypothalamic Circuits Causes Obesity
FSH versus estrogen: Who's guilty of breaking bones?
Mark S. Nanes, M.D., Ph.D., Caleb B. Kallen, M.D., Ph.D. 
The CAMplexities of Central Ghrelin
Volume 58, Issue 1, Pages (July 2000)
The Skeleton: The New Controller of Male Fertility?
Volume 73, Issue 9, Pages (May 2008)
Volume 116, Issue 2, Pages (January 2004)
Take out a sheet of paper for notes. This will be page 31
Johan Ruud, Jens C. Brüning  Current Biology 
Adipose Tissue as an Endocrine Organ
Selective Insulin and Leptin Resistance in Metabolic Disorders
Smurf1 Inhibits Osteoblast Differentiation, Bone Formation, and Glucose Homeostasis through Serine 148  Junko Shimazu, Jianwen Wei, Gerard Karsenty  Cell.
Enlightening the adrenal gland
Figure 1 Physiological functions of leptin and ghrelin
Volume 79, Pages S20-S23 (April 2011)
Volume 18, Issue 1, Pages (July 2013)
Veerle P. Persy, Marc D. McKee  Kidney International 
Silencing Insulin Resistance through SIRT1
Volume 11, Issue 3, Pages (March 2010)
Wai W. Cheung, Robert H. Mak  Kidney International 
Volume 67, Pages S33-S36 (June 2005)
Volume 76, Issue 8, Pages (October 2009)
Human Visceral-Fat-Specific Glucocorticoid Tuning of Adipogenesis
Bisphosphonate safety and efficacy in chronic kidney disease
Adipogenesis and Obesity: Rounding Out the Big Picture
p38δ and PKD1: Kinase Switches for Insulin Secretion
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism  Barbara B. Kahn, Thierry Alquier, David Carling,
Nitric oxide and vascular remodeling: Spotlight on the kidney
No Bones About It: Insulin Modulates Skeletal Remodeling
Insulin Resistance in the Defense against Obesity
Michael K. Badman, Jeffrey S. Flier  Gastroenterology 
The Hormonal Control of Food Intake
Leptin's RIGHT Turn to the Brain Stem
Volume 87, Issue 3, Pages (March 2015)
Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectives  Pierre Ronco, Christos Chatziantoniou 
Rajnish Mehrotra, Joel D. Kopple, Marsha Wolfson  Kidney International 
Treating obesity: Does antagonism of NPY fit the bill?
Volume 14, Issue 2, Pages (August 2011)
Volume 75, Issue 9, Pages (May 2009)
Immunity unmasks APOL1 in collapsing glomerulopathy
Volume 80, Issue 10, Pages (November 2011)
Protein nutrition as therapy for a genetic disorder of bone?
Vladimir A. Botchkarev  Journal of Investigative Dermatology 
Another niche for Notch
Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge?  Ellen G. Neven, Marc E. De Broe, Patrick.
Volume 74, Issue 10, Pages (November 2008)
Volume 75, Issue 8, Pages (April 2009)
Hap1 and GABA: Thinking about food intake
Removing the Bone Brake
Adipose Tissue as an Endocrine Organ
Presentation transcript:

Bone: from a reservoir of minerals to a regulator of energy metabolism Cyrille B. Confavreux  Kidney International  Volume 79, Pages S14-S19 (April 2011) DOI: 10.1038/ki.2011.25 Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 1 Interactions between bone and energy metabolism. Leptin inhibits bone formation through a serotonin central relay (brainstem to hypothalamus) and through hypothalamus-generated sympathetic tone. In turn, osteoblasts secrete osteocalcin, a hormone regulating energy metabolism, through its stimulation on insulin secretion and sensitivity. Adrβ2, β2-adrenergic receptor; AN, arcuate nucleus; Gla-OCN, carboxylated osteocalcin; Glu-OCN, uncarboxylated osteocalcin; ObRb, leptin receptor; OST-PTP, osteotesticular protein tyrosine phosphatase; SNS, sympathetic nervous system; VMH, ventromedial hypothalamic nucleus. Adapted from Confavreux.22 Kidney International 2011 79, S14-S19DOI: (10.1038/ki.2011.25) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 2 Osteoblast signaling pathways involved in energy metabolism regulation. Effects of insulin and sympathetic nervous system (SNS) on osteocalcin (OCN), osteotesticular protein tyrosine phosphatase (OST-PTP), and osteoprotegerin (OPG). Adrβ2, β2-adrenergic receptor; ATF4, activating transcription factor 4; InsR, insulin receptor. Adapted from Confavreux.22 Kidney International 2011 79, S14-S19DOI: (10.1038/ki.2011.25) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 3 Insulin and bone resorption affect circulating uncarboxylated osteocalcin (Glu-OCN). Insulin binds its receptor (InsR), which reduces osteoprotegerin (OPG) expression, thus enhancing osteoclast formation and activity. During bone resorption, acidification of the extracellular compartment decarboxylates inactive osteocalcin (Gla-OCN) to Glu-OCN. Glu-OCN is then released into the blood stream to affect target tissues. OST-PTP, osteotesticular protein tyrosine phosphatase. Adapted from Cell,27 with permission from Elsevier. Kidney International 2011 79, S14-S19DOI: (10.1038/ki.2011.25) Copyright © 2011 International Society of Nephrology Terms and Conditions